Fairman Jeff 4
4 · Vaxcyte, Inc. · Filed May 9, 2022
Insider Transaction Report
Form 4
Vaxcyte, Inc.PCVX
Fairman Jeff
VP, Research
Transactions
- Sale
Common Stock
2022-05-05$25.80/sh−888$22,914→ 325,339 total(indirect: By Trust)
Holdings
- 16,629
Common Stock
- 50,000(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.
- [F2]The price reported is a weighted-average price. The shares were sold at prices ranging from $25.58 to $26.19. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.